Statistics for BioStem Technologies, (id:11477 BSEM)
Valuation metrics
Market cap
227.21M
Enterprise value
231.53M
Trailing P/E (ttm)
-22.45
Forward P/E
6.69
PEG ratio
6.69
Price/Sales (ttm)
33.05
Price/Book (mrq)
-53.28
Enterprise Value/Revenue
33.68
Enterprise Value/EBITDA
-52.18
Overview
Shares outstanding
16.32M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
156.64K
Average volume (90 days)
Price summary
52-Week low
2.96
52-Week high
28.26
52-Week change
76.58%
Beta
1.78
50-Day moving average
13.87
200-Day moving average
10.68
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
January 27th, 2015
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2023
Profitability
Profit margin
87.17%
Operating margin
-96.66%
Operational effectiveness
Return on assets
-204.10%
Return on equity
179.11%
Income statement
Revenue (ttm)
1.22
Revenue per share (ttm)
1.22
Quarterly revenue growth (yoy)
Gross profit (ttm)
5.99M
EBITDA
0.00
Net income to common (ttm)
-7,074,861.00
Diluted EPS (ttm)
-0.73
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
109.86K
Total cash per share (mrq)
0.01
Total debt (mrq)
6.02M
Total Debt/Equity (mrq)
-1.71
Current ratio (mrq)
48.03%
Book value per share (mrq)
-0.08
Cash flow
Cash flow statement
-1,593,918.00
Levered free cash flow (LFCF)
1.58M